📰 Graybug Vision Inc News
Page 4 - Graybug Vision Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Graybug Vision Inc. Real-time updates on events, politics, business and more.
May 19, 2022
Graybug Vision (NASDAQ:GRAY – Get Rating) had its price objective decreased by Piper Sandler from $4.00 to $2.00 in a research report sent to investors on Wednesday morning, The Fly reports. GRAY has been the subject of several other reports. Cantor Fitzgerald reduced their target price on Graybug Vision from $4.00 to $2.50 in a […]
May 15, 2022
Graybug Vision, Inc. (NASDAQ:GRAY – Get Rating) was the target of a significant increase in short interest in the month of April. As of April 30th, there was short interest totalling 62,900 shares, an increase of 60.5% from the April 15th total of 39,200 shares. Approximately 0.5% of the company’s stock are sold short. Based […]
May 1, 2022
Graybug Vision, Inc. (NASDAQ:GRAY – Get Rating) has received an average rating of “Hold” from the seven research firms that are currently covering the stock, Marketbeat Ratings reports. Five analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 1-year price objective among analysts […]
April 14, 2022
Shares of Graybug Vision, Inc. (NASDAQ:GRAY – Get Rating) have received a consensus recommendation of “Hold” from the seven brokerages that are covering the company, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average twelve-month price target […]
April 1, 2022
Graybug Vision, Inc. (NASDAQ:GRAY – Get Rating) saw a significant decrease in short interest in March. As of March 15th, there was short interest totalling 75,100 shares, a decrease of 19.6% from the February 28th total of 93,400 shares. Based on an average trading volume of 89,300 shares, the short-interest ratio is presently 0.8 days. […]
January 20, 2022
BALTIMORE, Jan. 20, 2022 -- Graybug Vision, Inc. , a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of diseases of the retina and optic... | January 20, 2022
January 11, 2022
According to Future Market Insights (FMI), the demand for ocular drug delivery system is expected to rise considerably, enabling the market to surpass US$ 14,471.2 Mn in valuation by the end of 2021. The market is forecast to exhibit 6.8% CAGR between 2021 and 2031.Get Sample of the Report : https://www.futuremarket...
August 15, 2021
Ocular Drug Delivery Technology Market to Witness Revolutionary Growth by 2026 | Alimera Sciences, EyeGate Pharma, Graybug Vision
June 14, 2021
Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW). In these volatile markets we scrutinize hedge fund filings to get a reading on which direction each stock […]
June 11, 2021
Graybug Vision Inc (NASDAQ: GRAY) has not released any news since it printed its first-quarter 2021 earnings results May 12, but that didn’t stop the ...